10-06-2025
PA bills will expand access to opioid overdose reversal agents
PENNSYLVANIA (WTAJ) — Two bills will soon be introduced to help provide more resources to first responders and law enforcement to fight opioid overdoses.
Representatives Chris Pielli and Brian Munroe, in a memo to lawmakers, wrote that the current practice in Pennsylvania is 'outdated.' Noting that the Department of Health only allows the use of naloxone despite other options being available.
The CDC reported that deaths involving opioids were estimated to be over 54,000. However, from December 2023 to December 2024, drug overdose deaths in Pennsylvania dropped by 29.94%. Two states, Nevada and South Dakota, were the only ones with increases. Both saw increases of over 4%.
Pennsylvania lawmakers advance bill expanding no-cost breast cancer diagnostics
Naloxone is used by law enforcement and other first responders to reverse the effects of an opioid overdose. Naloxone works by attaching itself to opioid receptors and then reversing and blocking the effects of opioids.
In the CDC's most recent report, they also listed synthetic opioids, like fentanyl, as being the cause of the largest number of overdose deaths. Fentanyl is 50 times stronger than heroin and 100 times stronger than morphine, according to the representatives.
They argue that fentanyl is so strong that it can outlast the effects of naloxone and cause people to 're-overdose.' That's why they feel that first responders should have access to things like nalmefene, which is a longer-lasting opioid antagonist. Currently, nalmefene is only available by prescription.
'While naloxone is a crucial tool for first responders and law enforcement, it cannot be our only option,' The representatives said.
The two bills that they will be introducing would do the following:
Amend the Controlled Substance Drug, Device, and Cosmetic Act to allow nalmefene as an approved opioid antagonist for use over the counter.
Direct the Pennsylvania Department of Health to change their current standing order to include nalmefene as an approved opioid reversal agent for over the counter use.
'We cannot continue to discount the ability of other opioid antagonists to save lives. While our policy continues to stagnate, the illicit drug market evolves, adapts, and finds new ways to draw Pennsylvanians into the throes of addiction or, in an unfortunate number of cases, death,' the representatives added.
If you or someone you know is struggling with substance abuse, you can contact the Substance Abuse and Mental Health Services Administration's free, confidential, 24/7, 365-day-a-year treatment referral and information service at 1-800-662-HELP (4357).
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
